Continued Research Results About Long Term Benefits of Tecfidera

admin avatar

by admin |

Share this article:

Share article via email

Tecfidera is an oral medication that researchers believe effectively inhibits immune system cells and molecules and acts as an anti-oxidant that potentially protects against demyelination and the loss of neurons that occurs in Multiple Sclerosis (MS).

Learn more about Tecfidera here.

In this MD Magazine TV video, learn more about how research is showing that long-term Tecfidera’s usage can be a good treatment option for patients with multiple sclerosis, especially in the early stages.

Learn more about the recent clinical trials that studied Tecfidera and its role in treating RRMS.

Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

The Multiple Sclerosis Podcast


Survey Icon

Video